Analytical Data
-
Gene name
CKS2
- Application
-
Alternative Names
CKS-2
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P33552
-
Expression Region
1-79aa
-
Molecular Weight
17.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CKS2, or Cyclin-Dependent Kinase Subunit 2, is a crucial regulatory protein involved in cell cycle control and various cellular processes. Its primary function is to activate cyclin-dependent kinases (CDKs), which are essential for the progression of the cell cycle and the regulation of transcription. The study of CKS2 has garnered significant attention due to its implications in cancer biology, where its overexpression has been linked to tumorigenesis and poor prognosis in various malignancies. Understanding the structure and function of CKS2 through recombinant protein techniques enables researchers to explore its role in cell cycle regulation and its interactions with other proteins. Additionally, the study of CKS2 could provide insights into potential therapeutic targets for cancer treatment. Recombinant CKS2 protein production allows for detailed biochemical assays and structural studies, which can elucidate the mechanisms underlying its regulatory functions. This research is particularly relevant in the context of developing novel anticancer strategies that target the dysregulation of the cell cycle, making CKS2 an important focus in molecular oncology and drug development.
